Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes
-
Published:2019-04-03
Issue:
Volume:
Page:
-
ISSN:2169-1401
-
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
-
language:
-
Short-container-title:
您需要登录后可以查看相关数据！